The Impact of a Change in Tacrolimus Monitoring Immunoassay Techniques on Clinical Decision Making

Abstract

A change in tacrolimus monitoring assay would have resulted in different clinical decisions 51% of the time. Awareness of changes in assay technology must be heightened to enhance clinical decision making and prevent potential impact on morbidity among liver transplant patients.